Four out of five patients with heart failure are eligible for treatment with an SGLT2 inhibitor – Medical Xpress November 16, 2020Last Updated on November 16, 2020 by Sorry, Readability was unable to parse this page for content.Share on Social Media twitter facebook pinterest linkedin tumblr reddit email
